|Bid||0.00 x 3200|
|Ask||0.00 x 1200|
|Day's Range||120.96 - 126.69|
|52 Week Range||49.19 - 130.00|
|Beta (5Y Monthly)||1.15|
|PE Ratio (TTM)||689.83|
|Earnings Date||Feb. 18, 2020 - Feb. 23, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||141.73|
If you own shares in eHealth, Inc. (NASDAQ:EHTH) then it's worth thinking about how it contributes to the volatility...
eHealth (EHTH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
eHealth (EHTH) delivered earnings and revenue surprises of 28.33% and 29.29%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
EHealth (EHTH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Marsh & McLennan's (MMC) subsidiary collaborates with Xevant to offer a strategic optimization solution for employer-funded pharmacy benefit plans.
Marsh & McLennan (MMC) reaches an agreement with Construction Risk Partners, according to which the latter will buy the company's stock from JLT.